Medial EarlySign’s Co-founder Ori Geva and CEO Dr. Jeremy Orr describe the company's development, from its origin as a Silicon Valley-like startup operating out of an Israeli garage, to its growth and deployment of clinical algorithmic solutions with leading health systems in both Israel and the U.S.
Israel-based Medial EarlySign and Geisinger Health System have partnered to apply advanced artificial intelligence and machine learning algorithms to Medicare claims data to predict and improve patient outcomes.
Today on THCB Spotlights, Matthew speaks with Jeremy Orr, CEO of Medial EarlySign. Medial EarlySign does complex algorithmic detection of elevated risk trajectories for high-burden serious diseases, and the progression towards chronic diseases such as diabetes.
CMS has selected Geisinger and EarlySign, a machine learning company, for their joint proposal in the agency’s Artificial Intelligence Health Outcomes Challenge. The partnering organizations are among 25 others advancing to Stage 1 of the competition.